Design, synthesis, biological activity evaluation and in silico studies of new nicotinohydrazide derivatives as multi-targeted inhibitors for Alzheimer's disease-Reference-Cited by-同舟云学术

Design, synthesis, biological activity evaluation and in silico studies of new nicotinohydrazide derivatives as multi-targeted inhibitors for Alzheimer's disease

Published:2022-10 Issue: Volume:1265 Page:133441
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Tok Fatih^ORCID,Sağlık Begüm Nurpelin,Özkay Yusuf,Kaplancıklı Zafer Asım^ORCID,Koçyiğit-Kaymakçıoğlu Bedia

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference54 articles.

1. Alzheimer disease;Knopman;Nat. Rev. Dis. Primers,2021

2. Alzheimer's disease;Masters;Nat. Rev. Dis. Primers,2015

3. Alzheimer's disease: strategies for disease modification;Citron;Nat. Rev. Drug Discov.,2010

4. A systemic view of Alzheimer disease - insights from amyloid‑β metabolism beyond the brain;Wang;Nature,2017

5. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease;Hampel;Brain,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease;European Journal of Medicinal Chemistry;2024-12

2. Synthesis, in-vitro inhibition of cholinesterase and in silico studies of new hydrazide-hydrazones derived from Clopidogrel;Journal of Molecular Structure;2024-10

3. Design, synthesis, molecular modeling, in vitro evaluation of novel piperidine‐containing hydrazone derivatives as cholinesterase inhibitors;Drug Development Research;2024-08

4. Solid-liquid equilibrium of in some pure solvents and binary solvents from 293.15 K to 318.15 K;Chemical Engineering Communications;2024-06-13

5. Synthesis of new N‐(5,6‐methylenedioxybenzothiazole‐2‐yl)‐2‐[(substituted)thio/piperazine]acetamide/propanamide derivatives and evaluation of their AChE, BChE, and BACE‐1 inhibitory activities;Drug Development Research;2024-05-30